OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
2.53
-0.14 (-5.24%)
At close: Aug 15, 2025, 3:59 PM
2.44
-3.63%
After-hours: Aug 15, 2025, 07:38 PM EDT

OnKure Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
662K 560K 529K 50K
Gross Profit
-662K -560K -529K -50K
Operating Income
-54.39M -36.93M -29.77M -39.82M
Interest Income
2.01M 1.62M 254K n/a
Pretax Income
-52.67M -35.31M -29.51M -39.77M
Net Income
-52.67M -35.31M -29.51M -39.77M
Selling & General & Admin
10.59M 4.82M 3.9M 11.65M
Research & Development
43.8M 32.12M 25.86M 28.12M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
54.39M 36.93M 29.77M 39.77M
Interest Expense
300K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
54.39M 36.93M 29.77M 39.82M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
13.34M 13.34M 13.34M 1.81M
Shares Outstanding (Diluted)
13.34M 13.34M 13.34M 1.81M
EPS (Basic)
-3.95 -2.65 -2.21 -21.92
EPS (Diluted)
-3.95 -2.65 -2.21 -21.92
EBITDA
-51.71M -34.75M -29.38M -39.72M
EBIT
-52.37M -35.31M -29.77M -39.77M
Depreciation & Amortization
662K 560K 387K 50K